For Immediate Release
Office of the Press Secretary
September 25, 2002
Nomination
President Bush Announced His Intention to Nominate Mark McClellan to be Commissioner of the Food and Drug Administration
President George W. Bush today announced his intention to nominate Mark
B. McClellan to be Commissioner of the Food and Drug Administration.
Dr. McClellan is currently a member of the President's Council on
Economic Advisors, and he also serves as a senior policy director for
health care and related economic issues for the White House.
"As a doctor and researcher, Mark McClellan is uniquely qualified
to serve as Commissioner of the Food and Drug Administration. His
experience will be very valuable as the FDA faces new challenges in the
coming year, including the implementation of legislation I recently
signed to help protect the nation from bioterrorism threats, to help
speed access to breakthrough medical treatments, and to make medical
treatments safer. As head of the FDA, Mark will focus on empowering
consumers and ensuring rapid access to products that are safe and
effective," said President Bush.
Dr. McClellan was confirmed as a Member of the Council of Economic
Advisers by the Senate on July 19, 2001. Before joining the CEA, he
was Associate Professor of Economics at Stanford University, Associate
Professor of Medicine at Stanford Medical School, a practicing
internist, and Director of the Program on Health Outcomes Research at
Stanford University. He was also a Research Associate of the National
Bureau of Economic Research and a Visiting Scholar at the American
Enterprise Institute. Additionally, he was a Member of the National
Cancer Policy Board of the National Academy of Sciences, Associate
Editor of the Journal of Health Economics, and co-Principal
Investigator of the Health and Retirement Study (HRS), a longitudinal
study of the health and economic well-being of older Americans. From
1998-99, he was Deputy Assistant Secretary of the Treasury for Economic
Policy, where he supervised economic analysis and policy development on
a wide range of domestic policy issues.
His research studies have addressed measuring and improving the
quality of health care, the economic and policy factors influencing
medical treatment decisions, technological change in health care and
its consequences for health and medical expenditures, uninsurance, and
the relationship between health and economic well-being. He has twice
received the Arrow Award for Outstanding Research in Health Economics.
He earned his MD degree from the Harvard-MIT Division of Health
Sciences and Technology and his PhD in Economics from MIT. He
completed his residency training in internal medicine at Brigham and
Women's Hospital, and he is board-certified in Internal Medicine.
Dr. McClellan is married and has two three-year old daughters.
###
|